Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A practical guide to selecting between total market and total world funds for retirement, focusing on goals, risk tolerance, and costs.
28,577 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
The crypto industry is cooling as funding tightens and demand wavers. Syndicate Labs shuts down amid a wave of cost c...
Meme coins linked to a president jumped on headlines about alien disclosure, led by the TRUMP token. The move faded a...
Bitcoin logged a fresh multi-week low as markets opened, but hype defies altcoin crash with notable gains in HYPE and...
As software stocks wobble in 2026, one AI-first winner could rise from the noise. This article breaks down why a sele...
A veteran venture investor who backed Nvidia in 2016 reveals a third high-conviction call to lift hardware stocks, ty...
The Trade Desk once looked like a safe-growth engine in digital advertising. As growth slows and the landscape shifts...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...
What would it take for a single stock to reach a $2 trillion value in seven years? This article breaks down the drive...
State Street’s 2026 ETF Outlook pushes a shift to multi-coin crypto ETFs, but a standout XRP ticker shows the sector ...
Coty is navigating a shifting beauty market. This guide breaks down coty (coty) 2026 earnings, what the Q3 transcript...
Analysts debate Cardano's valuation as ADA weakens and on-chain metrics lag, challenging bulls and funds alike. The d...